Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
851 items

Medical College of Georgia scientists work to protect the vision of premature babies

Augusta University scientists have found a new target and drug that together appear to stop retinopathy of prematurity.

Bharti appointed director of National Eye Institute Intramural Research Program

The National Eye Institute (NEI) has tapped Kapil Bharti, Ph.D., to be the next scientific director of its intramural research program.

University of Houston researcher builds new model to examine Usher syndrome

Syndrome is a leading cause of combined deafness-blindness

Reading and visual health

Researchers at the State University of New York help explain how reading might contribute to myopia.

Extremely rare gene variants point to a potential cause of age-related macular degeneration

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

Congressman Pete Sessions visits NIH

Texas Congressman Pete Sessions visited the NIH March 27 to meet with NEI Director Michael F. Chiang, M.D., and to tour NEI’s Section on Ocular and Stem Cell Translational Research, led by Kapil Bharti, Ph.D.
blank

FDA-approved drug shows promise in lab models for blinding childhood disease 

A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10).
Rods and Cones image

Early study shows cones in retinal degeneration, thought to be dormant, may retain visual function

New UCLA research in mice suggests that “dormant” cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.
Nanoparticle. Courtesy of Biorender.

Tiny nanoparticle could have big impact on patients receiving corneal transplants

Using nanoparticles to encapsulate eye medication decreased graft rejection while requiring fewer and smaller doses.

Night vision tests in age-related macular degeneration precisely localize disease mechanisms

Researchers at the University of Alabama at Birmingham discovered that night vision tests at a specific location in the retina will be suitable for assessing treatments and preventions for AMD.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248